Government Affairs
Refine Search
Pharmaceutical
The Council of the European Union on Friday authorized the launch of an enhanced cooperation among EU member states for the creation of a unitary patent title (5538/11 and 6524/11 and 6524/11 ADD1). 14 March 2011
Pharmaceutical
In remarks to the US/Japan Business Council yesterday in Tokyo Japan, John Lechleiter, chairman, president and chief executive of US drug major Eli Lilly (NYSE: LLY) outlined two imperatives to secure the future of the research-based pharmaceutical industry and help stimulate the global economy: changing the way companies conduct research - or "reinventing invention" - and implementing public policies that promote an environment in which medical innovation can thrive. 10 March 2011
Pharmaceutical
The USA's Generic Pharmaceutical Association (GPhA), last week was joined by generic drugmakers Aetna, Apotex, Hospira, Mylan, Teva Pharmaceuticals and Watson Pharmaceuticals in writing to House Judiciary Committee Chairman Lamar Smith and Ranking Member John Conyers expressing objections to any changes to the inequitable conduct provisions in current patent law. 7 March 2011
Generics
The international medical humanitarian organization Medecins Sans Frontieres (MSF) marched alongside more than two thousand people living with HIV from across Asia and the United Nation's Special Rapporteur on the Right to Health in New Delhi yesterday, urging the Indian government to stand strong amid pressure from the European Union to accept provisions in a free trade agreement (FTA) that would restrict access to affordable medicines, as sensitive negotiations were taking place in Brussels (The Pharma Letters passim). 3 March 2011
Pharmaceutical
The Australian federal government's decision to block the listing of eight new medicines and vaccines on the Pharmaceutical Benefits Scheme will have a significant financial impact on patients, says trade group Medicines Australia's chief executive Brendan Shaw. 28 February 2011
Pharmaceutical
Last year's most important effort for the entire pharmaceutical industry in Finland, the reform of the national medicines policy, has now been finalized. The Ministry of Social Affairs and Health prepared the medicines policy in close co-operation with the drug trade body Pharma Industry Finland (PIF), which said it was extremely pleased with the joint preparation. 25 February 2011
Pharmaceutical
In a submission to the federal government last Friday, Canada's innovative pharmaceutical industry outlined concrete measures aimed at improving productivity and attracting more much-needed pharmaceutical and life sciences investment to Canada. 21 February 2011
Pharmaceutical
Industry group Medicines Australia's chief executive, Brendan Shaw, has set out four key policy priorities to arrest the decline in the number of clinical trials conducted in Australia. 21 February 2011
Pharmaceutical
Early last month, a three-day meeting of Indian state Health Ministers was concluded in Hyderabad to draw up a time bound action plan for creation of new posts of regulatory staff and upgrading of drug testing laboratories throughout the country, according to an editorial in local drug news source Pharma.biz. 18 February 2011
Pharmaceutical
The US Department of Health and Human Services has unveiled a new National Vaccine Plan to enhance coordination of all aspects of federal vaccine and immunization activities. Its goal is to ensure that all Americans can access the preventive benefits of vaccines. 18 February 2011
Pharmaceutical
As had been widely expected, the European Parliament yesterday voted for a new law ' the Falsified Medicines Directive - to prevent fake medicines from entering the legal supply chain. Internet sales will be covered by the law, which also introduces new safety and traceability measures, as well as sanctions against counterfeiters. This law still needs to be formally approved by the Council of Ministers. The vote follows months of intensive negotiations between the Parliament and member states. 17 February 2011
Pharmaceutical
The UK is ranked second among the 10 Western European markets surveyed in Business Monitor International's Business Environment Ratings for first-quarter 2011, moving up from fifth position in the previous quarter. 17 February 2011
Pharmaceutical
The USA-based AIDS Healthcare Foundation (AHF), which provides AIDS medical care and services to more than 152,000 individuals in 26 countries worldwide, has strongly condemned a move by House Republicans who, last Friday proposed slashing President Obama's 2011 funding for global AIDS programs by $813 million. 17 February 2011
Generics
The European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents research-based industry in Europe, sees an ambitious Free Trade Agreement (FTA) between the European Union and India as a significant opportunity. Such an agreement will establish a long-term partnership with one of the world's fastest growing economies and can help to deliver on Europe 2020 targets. 14 February 2011
Pharmaceutical
A new approach to research, along with public policies that support medical innovation, will help biopharmaceutical companies address stubborn diseases with potentially devastating personal and financial consequences, such as cancer and Alzheimer's disease, according to John Lechleiter, chairman, president and chief executive of Eli Lilly (NYSE: LLY), speaking at a keynote address at The Economist's 2011 Pharma Summit: Reinventing Pharma for a New Generation, held in London, UK, yesterday. 11 February 2011
Generics
According to a study from the Canadian Generic Pharmaceutical Association (CGPA), changes to Canada's drug patent system proposed by the European Union would add nearly $3 billion annually to Canada's prescription drug bill. 9 February 2011
Pharmaceutical
Last week's announcement by global drugs behemoth Pfizer (NYSE: PFE) that, as part of a series of cost-cutting moves, it would close its research site at Sandwich in the UK (The Pharma Letter February 2) generated thousands of column inches of press coverage, most of it critical of the UK government's industry and research policies, despite the drugmaker's protestations that this had nothing to do with its decision. And, on Friday, saw a damning report from the UK's largest organization for funding research on economic and social issues, the Economic and Social Research Council (ESRC). 7 February 2011
Generics
The USA's Patent Reform Bill (S 23), as announced last week, was broadly welcomed by the research-based pharmaceutical and biotechnology industries (The Pharma Letter February 4), but it received a very different response from makers of generic medicines. 7 February 2011
Pharmaceutical
A unanimous vote by the USA's Senate Judiciary Committee yesterday sent comprehensive patent reform legislation to the full Senate for the third time since 2008. The Patent Reform Act is authored by Senators Patrick Leahy (Democrat, Vermont), Orrin Hatch (Republican, Utah), and Chuck Grassley (Rep, Iowa). 4 February 2011
Pharmaceutical
As had been largely expected, the USA's Republican Senators failed to get enough votes to repeal President Barack Obama's signature health care reform law in a 47-51 party-line vote. But a vote to delete a small, revenue-raising provision of the sweeping law did pass, in a bipartisan vote. The House of Representatives, where Republicans have a majority, voted to repeal the legislation last month (The Pharma Letter January 20 and 25). 3 February 2011
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze